Wednesday, 4 April 2012

Pharmaceutical Manufacturer-Quality Control Management-Amylin Pharmaceuticals-Nurses' Health Study

Wanted: Female Nurses for Large, Ongoing Study

THURSDAY, March 1 -- Researchers are looking for 100,000 female nurses and nursing students to join the long-running Nurses' Health Study, which has yielded insight into a wide range of health issues, such as the benefits of physical activity and... read more..

Amylin Pharmaceuticals Announces Public Offering of Common Stock

SAN DIEGO, March 7, 2012 /PRNewswire/ -- Amylin Pharmaceuticals, Inc. (Nasdaq: AMLN) today announced that it is offering to sell shares of its common stock in an underwritten public offering.Credit Suisse Securities (USA) LLC is acting as sole book-running manager and underwriter... read more..

AMRI names quality control director for troubled plant, following lead of J&J, Novartis, others

Another pharmaceutical manufacturer has announced that it is beefing up quality control management after running afoul of FDA inspectors. AMRI ($AMRI) has named Tom McGrath as director of quality for aseptic services at its Burlington, MA, facility, which last year was cited in an FDA warning letter. A string of companies including Johnson & Johnson ($JNJ), Novartis ($NVS) and Hospira ($HSP) have recently named new leaders ranging from the plant level to the executive suite, whose focus, at least in part, will be on improving GMP in plants. Release | Story read more..

No comments:

Post a Comment